Monday, March 03, 2025 | 12:42 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

USFDA completes inspection of Lupin's Pithampur Unit -2 (Indore) facility

Image

Capital Market

With 6 observations

Lupin announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried out at its Pithampur Unit -2 (Indore) facility. The inspection was carried out between 14 January and 25 January 2019. The inspection at Pithampur Unit-2 (Indore) closed with 6 observations. The Company is confident of addressing the observations satisfactorily.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 26 2019 | 11:05 AM IST

Explore News